Close
CDMO Safety Testing 2026
Novotech

Critical Medicines Act Proposed By EU To Boost Drug Access

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.
- Advertisement -

A group involving 19 European Union member countries is pushing for steps to lessen the blocโ€™s dependence when it comes to Chinese imports as far as pharmaceutical ingredients are concerned, according to a paper dated May 2.

This move comes after a week of the European Commission proposing an overhaul of its 136-billion-euro pharmaceutical sector.

The proposed bill of the commission looks to revive the investment, reduce the shortage, and at the same time boost access to affordable drugs in a scenario where health budgets have been pushed to their limits due to the costs involved in the treatment of COVID-19. That said, the countries that are backing the said paper, which include the likes of France, Belgium, Spain, and Germany, want the EU to take more efficient steps in order to bolster the security of supplies when it comes to vital drug ingredients with the Critical Medicines Act.

The countries happen to be concerned when it comes to the global reliance on China in terms of key ingredients and just a handful of manufacturers. It is well to be noted that just five sites manufacture more than 50% of the total ingredients that meet the European benchmark.

As per the paper, the EU is becoming more and more dependent on imports from a few manufacturers as well as regions. Apparently, in 2019, across the world, above 40% of the APIs were sourced from China. Besides, all the API producers are dependent on China when it comes to intermediate inputs.

The commission is looking to roll out a list of critical medicines that require more tracking to make sure that shortages are avoided across the EU. The paper opines that for these medicines, the supply has to be monitored, the global value chains have to be mapped, and suppliers who show potential as well as vulnerabilities should be identified. The list is going to begin with those medications that have consistently been in short supply. The countries will also like to gauge measures that allow EU states to be dependent on one another in cases where no substitute supplies or drugs are found.

Latest stories

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Quantum Computing Optimizing Pharma Supply Chains

The global distribution of pharmaceutical products is facing unprecedented challenges that demand a new level of logistical precision and resilience. By utilizing advanced analytical models, companies can now navigate complex international networks with greater efficiency, ensuring that temperature-sensitive medicines and life-saving therapies reach their destinations without delay. This evolution toward a more intelligent and responsive supply chain is critical for maintaining public health and responding effectively to emerging medical needs on a global scale.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป